{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:13:54Z","timestamp":1788779634460,"version":"build-2803163510"},"reference-count":38,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background\/Objectives: Uterine leiomyosarcoma (uLMS) shares clinical and radiological similarities with benign uterine leiomyoma (LM), while validated discriminatory markers remain scarce. We compared cyclin E1 (CCNE1) expression in uLMS and LM tissue samples. Methods: This retrospective case-control study included 61 patients (16 uLMS, 45 LM) treated at a single institution (2017\u20132023). Of 22 eligible uLMS cases, six were excluded because suitable tissue was unavailable and they had significantly higher FIGO stages than the included cases. CCNE1 immunoreactivity was assessed using an adapted Allred score in five non-overlapping high-power fields selected from regions of highest expression. Two blinded pathologists independently scored each field, and the patient-level median was used for primary analysis. Results: The median CCNE1 Allred score was 6 (IQR 5\u20136) in uLMS versus 2 (IQR 0\u20133) in LM (p &lt; 0.001), with excellent interobserver agreement (ICC 0.94). The AUC was 0.941 (95% CI 0.875\u20130.990). A data-derived cut-off \u22654 yielded 93.8% sensitivity and 84.4% specificity. A conservative minimum-expression analysis yielded an AUC of 0.882. Postmenopausal status was strongly associated with uLMS but was nearly completely confounded with the diagnostic group (12\/16 uLMS vs. 0\/45 LM). A premenopausal-only analysis was directionally consistent but underpowered. Clinical symptoms and tumor size did not differ between the groups. Conclusions: CCNE1 immunoexpression was substantially higher in uLMS than LM, with excellent reproducibility. Diagnostic-performance estimates remain exploratory and were influenced by tumor-region sampling, menopausal imbalance, and under-representation of advanced-stage uLMS. Independent multicenter validation, particularly in premenopausal and advanced-stage disease, is required before clinical application.<\/jats:p>","DOI":"10.3390\/diseases14090324","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:30:46Z","timestamp":1788777046000},"page":"324","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Analysis of Cyclin E1 Expression in Uterine Leiomyosarcomas and Leiomyomas"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1443-0311","authenticated-orcid":false,"given":"Aleksandar","family":"Raki\u0107","sequence":"first","affiliation":[{"name":"Obstetrics and Gynecology Clinic Narodni Front, Kraljice Natalije 62, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazar","family":"Nejkovi\u0107","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology Clinic Narodni Front, Kraljice Natalije 62, 11000 Belgrade, Serbia"},{"name":"School of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Opri\u0107","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"},{"name":"Institute of Pathology, School of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 1, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"\u0110or\u0111evi\u0107","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology Clinic Narodni Front, Kraljice Natalije 62, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Raki\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Mathematics, University of Belgrade, Studentski trg 16, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9540-7123","authenticated-orcid":false,"given":"Aleksandar","family":"Juri\u0161i\u0107","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology Clinic Narodni Front, Kraljice Natalije 62, 11000 Belgrade, Serbia"},{"name":"School of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Obradovi\u0107","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 8, 11000 Belgrade, Serbia"},{"name":"Institute of Pathology, School of Medicine, University of Belgrade, Dr Suboti\u0107a Starijeg 1, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1159\/000494299","article-title":"Uterine Leiomyosarcoma","volume":"41","author":"Gabriel","year":"2018","journal-title":"Oncol. Res. Treat."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.diii.2019.07.007","article-title":"How to Differentiate Uterine Leiomyosarcoma from Leiomyoma with Imaging","volume":"100","author":"Sun","year":"2019","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.7150\/ijms.93464","article-title":"Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas","volume":"21","author":"Guo","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101992","DOI":"10.1016\/j.ijgc.2025.101992","article-title":"Uterine Leiomyosarcoma","volume":"35","author":"Bogani","year":"2025","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17588359231157645","DOI":"10.1177\/17588359231157645","article-title":"Uterine Sarcomas: Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up, by Spanish Group for Research on Sarcomas (GEIS)","volume":"15","author":"Ortega","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrm3629","article-title":"Control of Cell Cycle Transcription during G1 and S Phases","volume":"14","author":"Bertoli","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.molcel.2020.08.020","article-title":"Integrating Old and New Paradigms of G1\/S Control","volume":"80","author":"Rubin","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/cancers7010179","article-title":"Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors","volume":"7","author":"Peyressatre","year":"2015","journal-title":"Cancers"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Fagundes, R., and Teixeira, L.K. (2021). Cyclin E\/CDK2: DNA Replication, Replication Stress and Genomic Instability. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.774845"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41698-024-00787-4","article-title":"Cyclin E1\/CDK2 Activation Defines a Key Vulnerability to WEE1 Kinase Inhibition in Gynecological Cancers","volume":"9","author":"Kim","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rakic, A., Anicic, R., Rakic, M., and Nejkovic, L. (2023). Integrated Bioinformatics Investigation of Novel Biomarkers of Uterine Leiomyosarcoma Diagnosis and Outcome. J. Pers. Med., 13.","DOI":"10.3390\/jpm13060985"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijgo.2008.12.008","article-title":"FIGO Staging for Uterine Sarcomas","volume":"104","author":"Prat","year":"2009","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_14","unstructured":"WHO Classification of Tumours Editorial Board (2020). Female Genital Tumours. WHO Classification of Tumours, International Agency for Research on Cancer. [5th ed.]."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","article-title":"Problematic Uterine Smooth Muscle Neoplasms: A Clinicopathologic Study of 213 Cases","volume":"18","author":"Bell","year":"1994","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ahmad Fauzi, M.F., Wan Ahmad, W.S.H.M., Jamaluddin, M.F., Lee, J.T.H., Khor, S.Y., Looi, L.M., Abas, F.S., and Aldahoul, N. (2022). Allred Scoring of ER-IHC Stained Whole-Slide Images for Hormone Receptor Status in Breast Carcinoma. Diagnostics, 12.","DOI":"10.3390\/diagnostics12123093"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","article-title":"Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer","volume":"17","author":"Harvey","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.biocel.2003.12.005","article-title":"Cyclin E","volume":"36","author":"Geisen","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1038\/s41467-019-12536-4","article-title":"Genome-Wide Association and Epidemiological Analyses Reveal Common Genetic Origins Between Uterine Leiomyomata and Endometriosis","volume":"10","author":"Gallagher","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e2025182118","DOI":"10.1073\/pnas.2025182118","article-title":"Integrated Mutational Landscape Analysis of Uterine Leiomyosarcomas","volume":"118","author":"Choi","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","first-page":"3914232","article-title":"Analysis of the CDK4\/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib","volume":"2019","author":"Marienfeld","year":"2019","journal-title":"Sarcoma"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.21873\/anticanres.11068","article-title":"Molecular Pathology and Novel Clinical Therapy for Uterine Leiomyosarcoma","volume":"36","author":"Hayashi","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_23","first-page":"24","article-title":"Development of Spontaneous Uterine Tumors in Low Molecular Mass Polypeptide-2 Knockout Mice","volume":"62","author":"Hayashi","year":"2002","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.21873\/anticanres.15082","article-title":"Development of Uterine Leiomyosarcoma During Follow-up After Caesarean Section in a Woman with Uterine Leiomyoma","volume":"41","author":"Watanabe","year":"2021","journal-title":"Anticancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1097-0215(19990621)84:3<244::AID-IJC8>3.0.CO;2-2","article-title":"Expression of Cyclins and Cyclin-Dependent Kinases in Smooth Muscle Tumors of the Uterus","volume":"84","author":"Zhai","year":"1999","journal-title":"Int. J. Cancer"},{"key":"ref_26","first-page":"392","article-title":"Potential Biomarker for Human Uterine Leiomyosarcoma","volume":"6","author":"Hayashi","year":"2014","journal-title":"J. Clin. Med. Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Tanabe, Y., Hayashi, T., Okada, M., Aburatani, H., Tonegawa, S., Abiko, K., and Konishi, I. (2024). Potential Diagnostic Biomarkers for Human Mesenchymal Tumors, Especially LMP2\/\u03b21i and Cyclin E1\/MIB1 Differential Expression: PRUMIBIO Study. Georgian Med. News, 42\u201348.","DOI":"10.1101\/2024.06.27.24309614"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"104249","DOI":"10.1016\/j.labinv.2025.104249","article-title":"Assessing the Status of Cyclin E1 (CCNE1) from Gene to Protein Level in Ovarian and Endometrial Carcinomas: A Systematic Review","volume":"105(12)","author":"Trecourt","year":"2025","journal-title":"Lab. Investig."},{"key":"ref_29","first-page":"9361","article-title":"Identification of Key Genes and Pathways in Uterine Leiomyosarcoma through Bioinformatics Analysis","volume":"15","author":"Zang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ijc.31129","article-title":"Integrated Genome Analysis of Uterine Leiomyosarcoma to Identify Novel Driver Genes and Targetable Pathways","volume":"142","author":"Cuppens","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/PGP.0000000000000688","article-title":"P16, Ki67, P53, and WT1 Expression in Uterine Smooth Muscle Tumors: An Adjunct in Confirming the Diagnosis of Malignancy in Ambiguous Cases","volume":"40","author":"Delgado","year":"2021","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ejca.2007.04.008","article-title":"Upregulation of Wilms\u2019 Tumour Gene 1 (WT1) in Uterine Sarcomas","volume":"43","author":"Coosemans","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/35404","article-title":"Retinoblastoma Protein Recruits Histone Deacetylase to Repress Transcription","volume":"391","author":"Brehm","year":"1998","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Yang, Q., Falahati, A., Khosh, A., Mohammed, H., Kang, W., Corach\u00e1n, A., Bariani, M.V., Boyer, T.G., and Al-Hendy, A. (2022). Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma. Cells, 11.","DOI":"10.3390\/cells11233801"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5152\/dir.2014.14053","article-title":"Uterine Sarcomas: Clinical Presentation and MRI Features","volume":"21","author":"Santos","year":"2015","journal-title":"Diagn. Interv. Radiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00404-022-06515-2","article-title":"Prognostic Factors and Survival of Patients with Uterine Sarcoma: A German Unicenter Analysis","volume":"307","author":"Huss","year":"2023","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10397-015-0894-4","article-title":"The Prevalence of Occult Leiomyosarcoma at Surgery for Presumed Uterine Fibroids: A Meta-Analysis","volume":"12","author":"Pritts","year":"2015","journal-title":"Gynecol. Surg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41065-023-00273-0","article-title":"CCNE1 Is a Predictive and Immunotherapeutic Indicator in Various Cancers Including UCEC: A Pan-Cancer Analysis","volume":"160","author":"Zheng","year":"2023","journal-title":"Hereditas"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/9\/324\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:04:09Z","timestamp":1788779049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/9\/324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["diseases14090324"],"URL":"https:\/\/doi.org\/10.3390\/diseases14090324","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]}}}